Developmental Psychopathology and the Gene-environment Interaction
NCT ID: NCT04489069
Last Updated: 2024-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2019-01-16
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The final goal is to understand those factors that causing vulnerability to mental illness, eventually allowing better prevention and early detections of those persons with mental illness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
NCT04370730
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535
Minnesota Community-Based Cognitive Training in Early Psychosis
NCT03079024
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893
Psychopathology of Dissociative Disorders
NCT01388140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Longitudinal research allows a better grasp on the illness etiology as it gives the opportunity of directly investigate the possible causal mechanisms and of defining the origins of psychopathological condition in adults.
Many factors of risk interact, across neurodevelopment, in determining the person's vulnerability to mental illness. For instance, temperament and psychopathological factors were proved to have a role. However, the existing knowledge is still fragmented and should be integrated by new knowledge on genetic and environmental factors. Thus, combining observations of neurodevelopment, as measured with neuro-imaging techniques at subsequent timepoints, with psychopathological and neuropsychological evaluations, as well as with detailed information on genetic, environmental and temperamental indexes, is crucial, as no similar exhaustive investigations are still available.
Furthermore, it must be bared in mind that the gene by environment interaction generates complex epigenetic effects on neurodevelopment, which should be monitored through a longer time lapse.
This topic has been studying this topic for years, by research groups with sites in Friuli Venezia Giulia and Bosisio Parini (Lecco, Lombardia), by mean of cross-sectional and longitudinal studies, involving samples of children and adolescents at risk of psychopathology and referred because of behavioral and/or emotional difficulties, experienced in the past or still ongoing. Also, the research involved a cohort of Twins recruited from the normal population and whose data would allow more fine tuned analyses of the bene by environment interaction.
In those first phases of study, instruments assessing the psychopathological risk were adapted to the Italian population and the associated cognitive marker were identified.
Also, some analysis investigated the effect of the environment on the psychopathological risk. Moreover, the influence of genetic factors is under now study, mainly focussing on epigenetic factors.
The research that is presented here is the followup of the previous investigations. In the previous year (2019) 33 participants underwent the follow up from the sample of children at psychopathological risk and who were chidden/adolescents at the time of the baseline evaluation.
During the current year the Twins cohort will be followed up. Half or more of the participants tested ad the baseline are expected to participate, which correspond to about 30 couples (60 participants). The subjects will undergo i) a magnetic resonance, including structural MRI, DTI, resting state fMRI, fMRI (during the fMRI sequences a concurrent task, tapping attention and emotional processes, is presented); ii) a psychopathological evaluation; iii) a self-rating evaluation, filling questionnaires measuring temperaments and assessing the possible presence of behavioral problems; iv) a neurocognitive evaluation; v) a drawing of biological-genetic sample (saliva).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical, neuropsychological and MRI evaluations
MRI
Magnetic Resonance Imaging (sturctural MRI, fMRI resting state and task related, DTI)
Clinical and Neuropsychological evaluations
Clinical interviews and neuropsychological tests (paper/pencil and computer based)
Drawing DNA sample
Saliva sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
Magnetic Resonance Imaging (sturctural MRI, fMRI resting state and task related, DTI)
Clinical and Neuropsychological evaluations
Clinical interviews and neuropsychological tests (paper/pencil and computer based)
Drawing DNA sample
Saliva sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Sensory impairments that can hamper the correct execution of the neurocognitive tasks and interviews.
* Intellectual disability (i.e. IQ\<70 as estimated with the Wechsler Adult Intelligence Scale or the Wechsler Intelligence Scale for Children)
15 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Eugenio Medea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolina Bonivento, PhD
Role: PRINCIPAL_INVESTIGATOR
IRCCS E.Medea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS E.Medea
San Vito al Tagliamento, Pordenone, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
212/2019-VERSIONE2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.